N. Komeshima

发表

MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.

T. Tsuruo, M. Watanabe, N. Komeshima, 1988, Cancer research.

Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.

T. Tsuruo, M. Naito, M. Watanabe, 1991, Cancer research.

Role of DNA-binding in the cytotoxicity of an anthracycline, R20X2 and its morpholino analog, MX2.

T. Tsuruo, M. Watanabe, T. Takeuchi, 1989, The Journal of antibiotics.

New morpholino anthracyclines, MX, MX2, and MY5.

H. Umezawa, N. Ōtake, K. Tatsuta, 1987, The Journal of antibiotics.

Antitumor activity of new morpholino anthracyclines.

T. Tsuruo, H. Umezawa, N. Komeshima, 1988, The Journal of antibiotics.

Asymmetric Diels–Alder reaction catalysed by chiral alkoxyaluminium dichloride

K. Koga, S. Hashimoto, N. Komeshima, 1979 .

Asymmetric michael reaction via chiral α,β-unsaturated aldimines

K. Koga, S. Hashimoto, N. Komeshima, 1977 .

Stereochemical aspects of asymmetric diels-alder reaction catalyzed by chiral alkoxyaluminum dichlorides

K. Tomioka, K. Koga, S. Hashimoto, 1987 .

Absolute structure-cytotoxic activity relationships of steganacin congeners and analogues.

T. Tsuruo, K. Koga, S. Tanida, 1991, Journal of medicinal chemistry.

Synthesis and antitumor activity of 4'-O-acylanthracyclines.

H. Umezawa, N. Ōtake, K. Tatsuta, 1992, Journal of antibiotics (Tokyo. 1968).

New antitumor antibiotics, anguinomycins A and B.

Y. Hayakawa, N. Komeshima, K. Adachi, 1987, The Journal of antibiotics.

Stereoselective Reactions. II. Asymmetric Synthesis of β-Substituted Aldehydes by Michael Reaction using Chiral α, β-Unsaturated Aldimines

K. Koga, S. Hashimoto, N. Komeshima, 1979 .